Multiple Assemblies exist for SMTL entry 6mo7
N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor; X-RAY DIFFRACTION 1.85 Å

	SMTL ID 6mo7.1 Ligands N-({4-[3-(cyclopentylsulfamoyl)-4-methylphenyl]-3-methyl-1,2-oxazol-5-yl}methyl)acetamide Polypeptides Bromodomain-containing protein 2 Oligo-state monomer
	SMTL ID 6mo7.2 Ligands N-({4-[3-(cyclopentylsulfamoyl)-4-methylphenyl]-3-methyl-1,2-oxazol-5-yl}methyl)acetamide Polypeptides Bromodomain-containing protein 2 Oligo-state monomer
	SMTL ID 6mo7.3 Ligands N-({4-[3-(cyclopentylsulfamoyl)-4-methylphenyl]-3-methyl-1,2-oxazol-5-yl}methyl)acetamide Polypeptides Bromodomain-containing protein 2 Oligo-state monomer